Upgrade to SI Premium - Free Trial

Jefferies Outlines CVS Health (CVS) COVID Vaccine Opportunity, Reiterates $90 PT

January 15, 2021 8:48 AM
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $90.00 price target on CVS Health (NYSE: CVS) noting that investor ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments